These success, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of concentrating on ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. Long-term pain is complicated, and https://williamc703bws3.blogs100.com/profile